Acarbose Market is expected to reach US$ 163.9 million revenues by 2028

Acarbose is a kind of API that is white powder,It is used to product such as acarbose tablets/acarbose capsules/acarbose chewable tablets,which is a kind ofα – glucosidase inhibitor procucts. The medicine used drugs for type 2 diabetes, which is a pseudo-four sugar biosynthesis, can inhibit the small intestine cells activity of α – glucosidase, thereby delaying intestinal oligosaccharide, disaccharide or polysaccharide degradation, delaying the degradation and absorption of glucose and fructose in order to achieve the effect of reducing postprandial blood glucose.

China is the largest Acarbose market with about 71% market share. Korea is follower, accounting for about 12% market share.

The key players are Bayer, CKDBioCorporation, Hangzhou East China Pharmaceutical, Livzon Pharmaceutical Group, Hebei Huarong Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhebei Pharmaceutical etc. Top 3 companies occupied about 83% market share.

The global Acarbose market was valued at US$ 135 million in 2020 and it is expected to reach US$ 163.9 million by the end of 2027, growing at a CAGR of 2.8% during 2021-2027.

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Request for a free sample or purchase this report at:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Oral Acarbose
  • Injection Acarbose
  • Freeze-dried Powder

Segment by Application

  • Acarbose Tablets
  • Acarbose Capsules
  • Acarbose Chewable Tablets

By Company

  • Bayer
  • CKDBioCorporation
  • Hangzhou East China Pharmaceutical
  • Livzon Pharmaceutical Group
  • Hebei Huarong Pharmaceutical
  • Zhejiang Hisun Pharmaceutical
  • Zhebei Pharmaceutical

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)


Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479